Form 8-K - Current report:
SEC Accession No. 0001104659-24-087828
Filing Date
2024-08-09
Accepted
2024-08-09 16:30:39
Documents
15
Period of Report
2024-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421305d1_8k.htm   iXBRL 8-K 29558
2 EXHIBIT 10.1 tm2421305d1_ex10-1.htm EX-10.1 16114
3 EXHIBIT 10.2 tm2421305d1_ex10-2.htm EX-10.2 6210
  Complete submission text file 0001104659-24-087828.txt   232098

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20240805.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20240805_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20240805_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2421305d1_8k_htm.xml XML 3526
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36081 | Film No.: 241193270
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)